InspireMD, Inc. (NSPR)
USD 2.53
(-5.87%)
USD 2.53
(-5.87%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 47.64 Million USD | 93.25% |
| 2022 | 24.65 Million USD | -37.92% |
| 2021 | 39.71 Million USD | 123.39% |
| 2020 | 17.77 Million USD | 79.93% |
| 2019 | 9.88 Million USD | -19.6% |
| 2018 | 12.28 Million USD | 101.21% |
| 2017 | 6.1 Million USD | -35.1% |
| 2016 | 9.41 Million USD | 62.86% |
| 2015 | 5.77 Million USD | -49.58% |
| 2014 | 11.45 Million USD | -44.76% |
| 2013 | 20.74 Million USD | 29.54% |
| 2012 | 16.01 Million USD | 53.02% |
| 2011 | 10.46 Million USD | 175959.89% |
| 2010 | 5944.00 USD | 20.69% |
| 2009 | 4925.00 USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 55.65 Million USD | 32.43% |
| 2024 Q1 | 42.02 Million USD | -11.79% |
| 2023 Q3 | 50.02 Million USD | -6.75% |
| 2023 FY | 47.64 Million USD | 93.25% |
| 2023 Q1 | 19.92 Million USD | -19.19% |
| 2023 Q2 | 53.63 Million USD | 169.25% |
| 2023 Q4 | 47.64 Million USD | -4.75% |
| 2022 Q2 | 32.76 Million USD | -6.84% |
| 2022 Q3 | 28.06 Million USD | -14.36% |
| 2022 Q4 | 24.65 Million USD | -12.14% |
| 2022 Q1 | 35.17 Million USD | -11.43% |
| 2022 FY | 24.65 Million USD | -37.92% |
| 2021 Q4 | 39.71 Million USD | -6.79% |
| 2021 FY | 39.71 Million USD | 123.39% |
| 2021 Q3 | 42.6 Million USD | -8.13% |
| 2021 Q2 | 46.37 Million USD | -4.65% |
| 2021 Q1 | 48.63 Million USD | 173.58% |
| 2020 Q1 | 7.38 Million USD | -25.25% |
| 2020 Q2 | 17.74 Million USD | 140.22% |
| 2020 FY | 17.77 Million USD | 79.93% |
| 2020 Q3 | 15.6 Million USD | -12.01% |
| 2020 Q4 | 17.77 Million USD | 13.89% |
| 2019 Q3 | 11.62 Million USD | 25.18% |
| 2019 Q4 | 9.88 Million USD | -14.99% |
| 2019 FY | 9.88 Million USD | -19.6% |
| 2019 Q1 | 10.05 Million USD | -18.16% |
| 2019 Q2 | 9.28 Million USD | -7.69% |
| 2018 Q4 | 12.28 Million USD | -11.81% |
| 2018 Q3 | 13.93 Million USD | 47.11% |
| 2018 FY | 12.28 Million USD | 101.21% |
| 2018 Q1 | 7.28 Million USD | 19.29% |
| 2018 Q2 | 9.47 Million USD | 30.01% |
| 2017 Q2 | 8.9 Million USD | -15.27% |
| 2017 Q1 | 10.51 Million USD | 11.71% |
| 2017 Q3 | 7.11 Million USD | -20.14% |
| 2017 Q4 | 6.1 Million USD | -14.14% |
| 2017 FY | 6.1 Million USD | -35.1% |
| 2016 Q1 | 4.24 Million USD | -26.55% |
| 2016 FY | 9.41 Million USD | 62.86% |
| 2016 Q4 | 9.41 Million USD | -24.46% |
| 2016 Q2 | 3.02 Million USD | -28.84% |
| 2016 Q3 | 12.45 Million USD | 312.48% |
| 2015 Q1 | 17.72 Million USD | 54.67% |
| 2015 Q4 | 5.77 Million USD | -40.81% |
| 2015 Q3 | 9.76 Million USD | -28.03% |
| 2015 Q2 | 13.56 Million USD | -23.48% |
| 2015 FY | 5.77 Million USD | -49.58% |
| 2014 Q2 | 13.95 Million USD | -28.44% |
| 2014 FY | 11.45 Million USD | -44.76% |
| 2014 Q1 | 19.5 Million USD | 0.0% |
| 2014 Q4 | 11.45 Million USD | 15.85% |
| 2014 Q3 | 9.89 Million USD | -29.14% |
| 2013 FY | 20.74 Million USD | 29.54% |
| 2013 Q2 | 20.74 Million USD | 111.75% |
| 2013 Q3 | 17.68 Million USD | -14.74% |
| 2013 Q1 | 9.79 Million USD | -15.52% |
| 2012 Q4 | 11.59 Million USD | -14.82% |
| 2012 Q3 | 13.61 Million USD | -14.98% |
| 2012 FY | 16.01 Million USD | 53.02% |
| 2012 Q1 | 8.52 Million USD | -18.52% |
| 2012 Q2 | 16.01 Million USD | 87.8% |
| 2011 Q1 | 12.72 Million USD | 141333233.33% |
| 2011 FY | 10.46 Million USD | 175959.89% |
| 2011 Q2 | 11.34 Million USD | -10.83% |
| 2011 Q3 | 12.07 Million USD | 6.41% |
| 2011 Q4 | 10.46 Million USD | -13.3% |
| 2010 Q1 | 16.85 Thousand USD | 0.0% |
| 2010 Q2 | 5944.00 USD | -64.74% |
| 2010 Q3 | 944.00 USD | -84.12% |
| 2010 FY | 5944.00 USD | 20.69% |
| 2010 Q4 | 9.00 USD | -99.05% |
| 2009 Q2 | 4925.00 USD | 0.0% |
| 2009 FY | 4925.00 USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 31.36 Million USD | -51.894% |
| BrainsWay Ltd. | 62.97 Million USD | 24.343% |
| Cerus Corporation | 197.74 Million USD | 75.907% |
| Envoy Medical, Inc. | 7.64 Million USD | -523.599% |
| electroCore, Inc. | 16.38 Million USD | -190.737% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | -519.384% |
| IceCure Medical Ltd | 16.41 Million USD | -190.329% |
| Inogen, Inc. | 326.19 Million USD | 85.394% |
| OrthoPediatrics Corp. | 449.58 Million USD | 89.403% |
| Lucid Diagnostics Inc. | 27.27 Million USD | -74.708% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | -187.369% |
| MaxCyte, Inc. | 268.27 Million USD | 82.241% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | -488.38% |
| Nexalin Technology, Inc. | 3.63 Million USD | -1211.787% |
| Orthofix Medical Inc. | 925.31 Million USD | 94.851% |
| PAVmed Inc | 33.11 Million USD | -43.854% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | 66.788% |
| RxSight, Inc. | 182.55 Million USD | 73.901% |
| Sight Sciences, Inc. | 166.65 Million USD | 71.412% |
| SI-BONE, Inc. | 230.42 Million USD | 79.324% |
| TELA Bio, Inc. | 78.04 Million USD | 38.957% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | 81.087% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | -344.017% |
| Acutus Medical, Inc. | 53.96 Million USD | 11.707% |
| Talis Biomedical Corporation | 98.34 Million USD | 51.553% |
| Spectral AI, Inc. | 10.69 Million USD | -345.595% |
| Nano-X Imaging Ltd. | 218.64 Million USD | 78.21% |
| CVRx, Inc. | 115.22 Million USD | 58.654% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | 18.782% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -1429.346% |
| Bioventus Inc. | 810.91 Million USD | 94.125% |
| Venus Concept Inc. | 93.65 Million USD | 49.129% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | -85.201% |
| LivaNova PLC | 2.42 Billion USD | 98.039% |
| 908 Devices Inc. | 202.98 Million USD | 76.528% |
| Alphatec Holdings, Inc. | 805.2 Million USD | 94.083% |
| Nemaura Medical Inc. | 14.56 Million USD | -227.146% |
| NeuroPace, Inc. | 107.65 Million USD | 55.743% |
| LENSAR, Inc. | 69.58 Million USD | 31.533% |
| Apyx Medical Corporation | 79.24 Million USD | 39.875% |
| Cutera, Inc. | 346.29 Million USD | 86.242% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | -13.393% |
| BioSig Technologies, Inc. | 1.79 Million USD | -2549.778% |
| Anika Therapeutics, Inc. | 270.63 Million USD | 82.396% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | -11.678% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 98.74% |
| Axonics, Inc. | 719.92 Million USD | 93.382% |
| Outset Medical, Inc. | 313.8 Million USD | 84.817% |
| IRIDEX Corporation | 34.43 Million USD | -38.352% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | 88.228% |
| IRadimed Corporation | 92.15 Million USD | 48.302% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -806.795% |
| INVO Bioscience, Inc. | 20.88 Million USD | -128.09% |
| Telesis Bio, Inc. | 70.41 Million USD | 32.336% |
| Viemed Healthcare, Inc. | 154.1 Million USD | 69.084% |
| Varex Imaging Corporation | 1.24 Billion USD | 96.187% |
| Quipt Home Medical Corp. | 247.4 Million USD | 80.743% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -411.74% |
| Pulmonx Corporation | 178.95 Million USD | 73.377% |
| Dynatronics Corporation | 25.94 Million USD | -83.662% |
| Modular Medical, Inc. | 13.8 Million USD | -245.064% |
| ReShape Lifesciences Inc. | 10.72 Million USD | -344.141% |
| Semler Scientific, Inc. | 78.06 Million USD | 38.97% |
| InMode Ltd. | 863.28 Million USD | 94.481% |
| Bruker Corporation | 4.24 Billion USD | 98.879% |
| Cytosorbents Corporation | 53.26 Million USD | 10.547% |
| DexCom, Inc. | 6.26 Billion USD | 99.239% |
| Align Technology, Inc. | 6.08 Billion USD | 99.217% |
| Viveve Medical, Inc. | 25.91 Million USD | -83.858% |
| ZimVie Inc. | 1.2 Billion USD | 96.047% |
| Movano Inc. | 9.42 Million USD | -405.711% |
| Cytek Biosciences, Inc. | 497.66 Million USD | 90.427% |
| Nexalin Technology, Inc. | 3.63 Million USD | -1211.787% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | 18.782% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | 94.999% |
| Profound Medical Corp. | 43.68 Million USD | -9.057% |
| Insulet Corporation | 2.58 Billion USD | 98.159% |
| enVVeno Medical Corporation | 48.63 Million USD | 2.04% |
| Surmodics, Inc. | 185.73 Million USD | 74.349% |
| iCAD, Inc. | 41.41 Million USD | -15.03% |
| Nuwellis, Inc. | 9.77 Million USD | -387.646% |
| Biotricity, Inc. | 5.94 Million USD | -701.716% |
| iRhythm Technologies, Inc. | 433.14 Million USD | 89.001% |
| Aethlon Medical, Inc. | 8.24 Million USD | -477.772% |
| PAVmed Inc. | 33.11 Million USD | -43.854% |
| BIOLASE, Inc. | 35.1 Million USD | -35.731% |
| Beyond Air, Inc. | 56.96 Million USD | 16.359% |
| FONAR Corporation | 214.24 Million USD | 77.762% |
| AxoGen, Inc. | 196.82 Million USD | 75.794% |
| Vivani Medical, Inc. | 45.79 Million USD | -4.031% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | 83.072% |
| Inari Medical, Inc. | 674.23 Million USD | 92.934% |
| UFP Technologies, Inc. | 404.13 Million USD | 88.211% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | -103.615% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | -401.341% |
| Tenon Medical, Inc. | 6.34 Million USD | -650.875% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | -406.463% |
| Co-Diagnostics, Inc. | 103.64 Million USD | 54.034% |
| AdaptHealth Corp. | 4.61 Billion USD | 98.969% |
| Sintx Technologies, Inc. | 15.36 Million USD | -210.075% |
| NanoVibronix, Inc. | 6.67 Million USD | -613.86% |
| Quanterix Corporation | 425.01 Million USD | 88.79% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -411.74% |
| Sensus Healthcare, Inc. | 53.72 Million USD | 11.324% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | 97.271% |
| TransMedics Group, Inc. | 706.04 Million USD | 93.252% |
| ReWalk Robotics Ltd. | 63.19 Million USD | 24.606% |
| NeuroMetrix, Inc. | 21.42 Million USD | -122.377% |
| Hyperfine, Inc. | 94.19 Million USD | 49.423% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | 82.265% |
| Biomerica, Inc. | 9.25 Million USD | -414.837% |
| Bone Biologics Corporation | 3.73 Million USD | -1174.639% |
| AVITA Medical, Inc. | 144.33 Million USD | 66.993% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -878.591% |
| Silk Road Medical, Inc | 265.3 Million USD | 82.042% |